| dc.contributor.author | Lubberman, FJE | |
| dc.contributor.author | Gelderblom, H | |
| dc.contributor.author | Wilmer, CM | |
| dc.contributor.author | Kweekel, DM | |
| dc.contributor.author | Desar, IME | |
| dc.contributor.author | Colbers, A | |
| dc.contributor.author | Burger, D | |
| dc.contributor.author | van der Graaf, WTA | |
| dc.contributor.author | van Erp, N | |
| dc.date.accessioned | 2017-08-29T09:58:44Z | |
| dc.date.issued | 2017-10 | |
| dc.identifier.citation | British journal of clinical pharmacology, 2017, 83 (10), pp. 2312 - 2314 | |
| dc.identifier.issn | 0306-5251 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/792 | |
| dc.identifier.eissn | 1365-2125 | |
| dc.identifier.doi | 10.1111/bcp.13333 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 2312 - 2314 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.subject | Humans | |
| dc.subject | Gastrointestinal Neoplasms | |
| dc.subject | Gastrointestinal Stromal Tumors | |
| dc.subject | Antineoplastic Agents | |
| dc.subject | Gastrectomy | |
| dc.subject | Cross-Over Studies | |
| dc.subject | Food-Drug Interactions | |
| dc.subject | Carbonated Beverages | |
| dc.subject | Imatinib Mesylate | |
| dc.title | Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy? | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2017-05-08 | |
| rioxxterms.funder | The Institute of Cancer Research | |
| rioxxterms.identifier.project | Unspecified | |
| rioxxterms.versionofrecord | 10.1111/bcp.13333 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2017-10 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | British journal of clinical pharmacology | |
| pubs.issue | 10 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 83 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Clinical and Translational Sarcoma | |
| dc.contributor.icrauthor | van der Graaf, Wilhelmina | |
| dc.contributor.icrauthor | Marsden, | |
